神經診斷市場規模、佔有率和成長分析（按疾病、技術、最終用途和地區分類）－2026-2033年產業預測

預計到 2024 年，神經診斷市場規模將達到 107.9 億美元，到 2025 年將達到 117.6 億美元，到 2033 年將達到 234.3 億美元，在預測期（2026-2033 年）內，複合年成長率為 9%。

神經診斷市場的主要驅動力是神經系統疾病發生率的上升、人口老化以及技術的顯著進步。這些創新透過融合蛋白質體學和基因組學的新型診斷技術，提高了神經退化性疾病準確性，從而實現了疾病的早期精準檢測。在全球範圍內，醫院和診斷中心數量的增加，透過提升先進診斷技術的可近性，加速了市場成長。神經診斷中對生物學分析的需求不斷成長，也進一步推動了這個趨勢。然而，也存在一些潛在挑戰，例如一些開發中國家嚴格的法規環境和對神經診斷服務需求疲軟。儘管如此，神經診斷技術在臨床研究中的日益廣泛應用，正在開闢新的市場機遇，尤其是在醫療基礎設施不斷完善、支出不斷成長的新興經濟體，這為充滿活力的行業前景奠定了基礎。

神經診斷市場促進因素

神經診斷市場的成長主要受神經系統疾病（包括癲癇、帕金森氏症和阿茲海默症）盛行率上升的驅動。隨著這些疾病患者數量的持續成長，醫療機構對先進診斷技術的需求也日益增加。這種需求的激增推動了先進神經診斷工具的應用，以實現疾病的精準識別和後續觀察，從而促進了整個市場的發展。此外，改善患者預後和提升診斷能力的努力也進一步推動了神經診斷技術的擴張。

神經診斷市場的限制因素

神經診斷市場面臨的一大挑戰是嚴格的監管，這些監管涵蓋了神經診斷設備的批准和銷售。冗長的流程和複雜的指南可能會扼殺創新，減緩新技術的應用，最終限制市場的成長潛力。在醫療保健監管嚴格的地區，這種情況尤其突出，合規方面的複雜性可能成為新技術進入市場的障礙。因此，整個神經診斷市場的發展可能會受到阻礙，進而阻礙能夠改善患者照護和治療方案的關鍵診斷工具的研發。

神經診斷市場趨勢

神經診斷市場正日益受到基因組學和個人化醫療進步的影響，這些進步正在改變神經系統疾病的診斷和治療方法。借助尖端的基因分析技術，醫療機構能夠為每位患者提供更有效、更個人化的治療方案，進而推動精準醫療的轉型。這一趨勢促使人們採用先進的診斷技術，透過專注於特定的基因譜來改善患者照護，最終獲得更好的治療效果。因此，對創新神經診斷工具和調查方法的需求預計將顯著成長，這反映了神經病學領域對個人化醫療解決方案的日益重視。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球神經診斷市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 診斷和影像系統
  • 腦電圖（EEG）系統
  • 肌電圖（EMG）產品
  • 磁振造影（MRI）系統
  • 超音波影像設備
  • 電腦斷層掃描（CT）掃描儀
  • 腦磁圖（MEG）系統
  • 正子斷層掃描（PET）系統
  • 血管造影術系統
  • 其他系統
• 臨床檢測設備
  • PCR
  • 次世代定序（NGS）
  • 桑格定序
  • 其他臨床診斷產品
• 試劑和耗材
  • 培養基和血清
  • 溶劑
  • 酵素、蛋白質和胜肽
  • 探測
  • 緩衝
  • 抗體
  • 其他試劑

全球神經診斷市場規模（按疾病和複合年成長率分類）（2026-2033 年）

• 神經退化性疾病
• 癲癇
• 中風
• 頭痛疾病
• 睡眠障礙
• 其他疾病

全球神經診斷市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 醫院及手術中心
• 神經病學中心
• 門診治療中心
• 診斷檢查室和影像中心
• 研究機構和學術機構

全球神經診斷市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（US）
• GE Healthcare（US）
• Koninklijke Philips（Netherlands）
• FUJIFILM（Japan）
• Lifelines Neuro（US）
• Advanced Brain Monitoring（US）
• Nihon Kohden（Japan）
• Hoffmann-La Roche（Switzerland）
• Canon Medical Systems（Japan）
• Danaher（US）
• Abbott Laboratories（US）
• Becton, Dickinson and Company（BD）（US）
• Johnson & Johnson（US）
• Medtronic（Ireland）
• Stryker（US）
• Intuitive Surgical（US）
• Zimmer Biomet（US）
• Smith & Nephew（UK）

結論與建議

Neurodiagnostics Market size was valued at USD 10.79 Billion in 2024 and is poised to grow from USD 11.76 Billion in 2025 to USD 23.43 Billion by 2033, growing at a CAGR of 9% during the forecast period (2026-2033).

The neurodiagnostics market is primarily driven by rising neurological disorder incidence, an aging population, and significant technological advancements. These innovations facilitate early and accurate disease detection, enhancing precision in identifying neurodegenerative conditions through novel diagnostic techniques incorporating proteomics and genomics. Globally, the proliferation of hospitals and diagnostic centers accelerates market growth by improving access to advanced diagnostic technologies. Increasing demand for biological profiling in neurological diagnosis further bolsters this trend. However, potential challenges include stringent regulatory environments and low demand for neurodiagnostic services in some developing countries. Conversely, the expanding application of neurodiagnostics in clinical research opens new market opportunities, particularly in emerging economies where healthcare infrastructure is improving and expenditure is rising, setting the stage for a dynamic industry outlook.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurodiagnostics Market Segments Analysis

Global Neurodiagnostics Market is segmented by Product, Condition, End-User and region. Based on Product, the market is segmented into Diagnostic and Imaging Systems, Clinical Testing Instruments and Reagents & Consumables. Based on Condition, the market is segmented into Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Diseases. Based on End-User, the market is segmented into Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers and Research Laboratories & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurodiagnostics Market

The driving force behind the growth of the neurodiagnostics market is the rising prevalence of neurological disorders including epilepsy, Parkinson's disease, and Alzheimer's disease. As the number of individuals affected by these conditions continues to grow, there is a heightened demand for advanced diagnostic technologies within healthcare settings. This surge in demand is prompting the adoption of sophisticated neurodiagnostic tools aimed at accurately identifying and monitoring these disorders, thereby fostering the overall development of the market. Efforts to enhance patient outcomes and improve diagnostic capabilities further support this upward trend in neurodiagnostic technology utilization.

Restraints in the Neurodiagnostics Market

A significant challenge within the neurodiagnostics market stems from stringent regulations governing the clearance and marketing of neurodiagnostic devices. These lengthy processes and intricate guidelines can hinder innovation and slow the deployment of new technologies, ultimately limiting the market's growth potential. This situation is particularly pronounced in regions with stringent healthcare regulations, where the complexities involved in compliance can act as barriers to entry for new advancements. As a result, the overall progress of the neurodiagnostics market may be adversely affected, impeding the evolution of crucial diagnostic tools that could enhance patient care and treatment options.

Market Trends of the Neurodiagnostics Market

The neurodiagnostics market is increasingly influenced by advancements in genomics and personalized medicine, which are transforming the approach to diagnosing and treating neurological disorders. By leveraging cutting-edge genetic analysis, healthcare providers can offer tailored therapies that are more effective for individual patients, facilitating a shift towards precision medicine. This trend is leading to the adoption of sophisticated diagnostic techniques that enhance patient care by focusing on specific genetic profiles, ultimately improving treatment outcomes. As a result, the demand for innovative neurodiagnostic tools and methodologies is poised for significant growth, reflecting a broader commitment to personalized healthcare solutions in neurology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Neurodiagnostics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Diagnostic and Imaging Systems
  • Electroencephalogram (EEG) Systems
  • Electromyography (EMG) Products
  • Magnetic Resonance Imaging (MRI) Systems
  • Ultrasound Imaging Systems
  • Computed Tomography (CT) Scanner
  • Magnetoencephalogram (MEG) System
  • Position emission tomography (PET) System
  • Angiography System
  • Other Systems
• Clinical Testing Instruments
  • PCR
  • Next-Generation Sequencing (NGS)
  • Sanger Sequencing
  • Other Clinical Diagnostic Products
• Reagents & Consumables
  • Media and Serum
  • Solvents
  • Enzymes, Protein & Peptides
  • Probes
  • Buffers
  • Antibodies
  • Other Reagents

Global Neurodiagnostics Market Size by Condition & CAGR (2026-2033)

• Market Overview
• Neuro Degenerative Diseases
• Epilepsy
• Stroke
• Headache Disorders
• Sleep Disorders
• Other Diseases

Global Neurodiagnostics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Surgery Centers
• Neurology Centers
• Ambulatory Care Centers
• Diagnostic Laboratories & Imaging Centers
• Research Laboratories & Academic Institutes

Global Neurodiagnostics Market Size & CAGR (2026-2033)

• North America (Product, Condition, End-User)
  • US
  • Canada
• Europe (Product, Condition, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Condition, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Condition, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Condition, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifelines Neuro (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Brain Monitoring (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations